CEACAM5 and cancer: The tumor markers had very low sensitivity and PPV for whole-body cancers; those of CEA (cut-off: 5 ng/mL) were 6.6% and 4.1%, respectively, and those of CA19-9 (cut-off: 37 U/mL) were 10.8% and 5.8%, respectively.